The European Medicines Agency has recommended the granting of marketing authorisations under exceptional circumstances for two inactivated Bluetongue vaccines for sheep and cattle respectively through the centralised procedure. These recommendations will add two additional vaccines to the therapeutic arsenal of bluetongue vaccines.